MedTrace Logo

Management of Prelabor Rupture of the Membranes at Term

NCT04307069 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 524

Last updated 2024-04-12

No results posted yet for this study

Summary

Prolonged rupture of membranes has been associated with increased risk of chorioamnionitis and endometritis. In this study the investigators will investigate whether an early intervention to augment labor with oxytocin is superior to expected management for spontaneous delivery (up to 24 hours).

Conditions

  • Fetal Infection
  • Chorioamnionitis
  • Endometritis
  • Cesarean Section Complications

Interventions

DRUG

Oxytocin

The drug wil be adminisrate for augmentation of labor at admission.

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Gal Bachar, MD · Rambam Medical Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04307069 on ClinicalTrials.gov